Skip to main content

Table 2 Costs borne by drug sellers or CHWs and household costs under iCCM strategy in US$ in 2018 and their sources

From: Cost-effectiveness analysis of integrated community case management delivery models utilizing drug sellers and community health workers for treatment of under-five febrile cases of malaria, pneumonia, diarrhoea in rural Uganda

 

iCCM trained-Drug seller

iCCM trained-CHW

Source

Cost borne by drug sellers or CHWs

 Value of time lost per consultationa

0.17

0.17

[32]

 Value of time lost per household visitb

0.00

0.17

[32]

 Value of time per health facility visitc

0.00

0.23

[32]

 Non-reimbursed direct travel cost

0.00

2.40

[12]

 Non-reimbursed telephone airtime cost

0.00

1.50

[12]

 Artemether + Lumefantrine (20 + 120 mg) 6 × 1 pack

0.26

0.00

[29]

 Artemether + Lumefantrine (20 + 120 mg) 6 × 2 pack

0.50

0.00

 Artesunate 50 mg rectal capsules

0.60

0.00

 Amoxicillin 125 mg DT per strip of 10 tablets

0.07

0.00

 ORS powder sachet for 1000 ml

0.05

0.00

 Zinc sulphate (20 mg) DT per strip of 10 tablets

0.07

0.00

Total

1.72

4.47

Household costs per U5 care-giver

 Direct medical costsd

0.2–2.4

0.00

[12]

 Direct non-medical coste

0.94

0.31

[12]

 Time lost traveling to a health provider

0.17

0.11

[12, 15]

 Time spent at a health provider

0.17

0.17

[12, 32]

Total

2.68

0.59

 
  1. aRefers to the value of time a drug seller or CHW spends diagnosing and treating a sick U5
  2. bRefers to the value of time a CHW spends following up on a previously treated U5 case
  3. cRefers to the value of time to collect new drugs, deliver service statistics, meet with the supervisor
  4. dDirect medical costs include costs for drugs or diagnostic tests
  5. eDirect non-medical costs include costs for transport to & from the provider and special food to improve health